Eloxx Pharmaceuticals Inc (OTCPK:ELOX)
$ 0.68557 -0.05443 (-7.36%) Market Cap: 2.15 Mil Enterprise Value: 3.31 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 34/100

Eloxx Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript

Mar 14, 2019 / 12:30PM GMT
Release Date Price: $499.6 (-3.40%)
Gregory Allen Harrison
Barclays Bank PLC, Research Division - Research Analyst

Hello, everyone. Welcome to the final day of the Barclays Global Healthcare Conference. I'm Greg Harrison, an associate on Geoff Meacham's team. And today, we're lucky enough to have Eloxx Pharmaceuticals and Robert Ward, Chairman and CEO, with us today. Robert?

Robert E. Ward
Eloxx Pharmaceuticals, Inc. - Chairman & CEO

Thank you, [Greg], and we appreciate being included in the Barclay's Global Health Conference this year.

During the course of my presentation today, I'll be making forward-looking statements, and so I'd ask you that you refer to our most recent filings with the SEC. And we did record our earnings call just this past week.

So we're very excited to have announced that Dr. Susan Schneider has joined the company now to lead our ophthalmology program. For this year at Eloxx, with our cystic fibrosis program poised to achieve topline data in Phase II, our cystinosis program also on track for Phase II readout, our expansion to inherited retinal

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot